Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Psychiatr Danub ; 20(4): 456-60, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19011585

ABSTRACT

OBJECTIVES: To determine the influence of global cerebral ischemia on the activation of extracellular-regulated kinases (ERK) and c-Jun N-terminal kinases (JNK) in optic nerves of rats exposed to different reperfusion periods. MATERIALS AND METHODS: Transient global cerebral ischemia (20-min duration) was induced by the four-vessel occlusion method. After different reperfusion periods (5 and 10 min; 1; 6 and 12 h after ischemia), optic nerves were extracted and ERK and JNK activation signals were determined by Western immunoblot analyses. RESULTS: The activation signals of ERK and JNK were detected within first 10 min of reperfusion, but striking activation for both enzymes was found 1 h after ischemia. After a transient decrease, the activation of ERK returned to peak level after 12 h of reperfusion in the second wave of kinase activation. In that period, a slight increase of JNK activation was registered. CONCLUSION: Our results demonstrated for the first time that ERK and JNK were activated in rat optic nerves during early and later periods of reperfusion, suggesting their potential active role in the response of cerebral white matter tissue to ischemic injury.


Subject(s)
Brain Ischemia/genetics , Extracellular Signal-Regulated MAP Kinases/genetics , JNK Mitogen-Activated Protein Kinases/genetics , Optic Nerve/blood supply , Reperfusion Injury/genetics , Animals , Blotting, Western , Brain/pathology , Brain Ischemia/pathology , Enzyme Activation/genetics , Immunoenzyme Techniques , Optic Nerve/pathology , Rats , Rats, Wistar/genetics , Reperfusion Injury/pathology , Vertebrobasilar Insufficiency/genetics , Vertebrobasilar Insufficiency/pathology
2.
Psychiatr Danub ; 20(3): 269-76, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18827752

ABSTRACT

OBJECTIVE: Kainic acid (KA) is used as an experimental agent which produces convulsions and neurotoxic lesions. Lamotrigine (LTG) is an antiepileptic drug, a glutamate release inhibitor, with action at the neuronal voltage-gated sodium channel. The aim of the present study was to investigate the Na+-K+-ATPase activity in the hippocampus and cortex of rats with KA-induced convulsions. Further, this study was also designed to investigate the influence of the LTG pre-treatment on the mentioned hippocampal and cortex changes. MATERIALS AND METHODS: The study was carried out on Hannover-Wistar rats. Na+, K+-ATPase activity from hippocampal and temporal cortex tissue was determined two hours after a single subcutaneous KA (8 mg/kg) injection as well as on the third or the fifth experimental day. LTG (30 mg/kg i.p.) was used one hour before KA application and during the next two or four consecutive days. All animals of KA and KA+LTG groups were observed during the first 2 hours after KA application and their behavior was noted. Only animals with characteristically KA-induced behavioral changes observed were used in the study. KA typical behavioral changes were confirmed with electroencephalography. RESULTS: After KA application, Na+, K+-ATPase activity was significantly inhibited. Na+-K+-ATPase activity inhibition in the hippocampus of the LTG pretreated rats on the fifth experimental day was statistically less pronounced than in KA treated rats. The LTG pretreatment showed also a protective effect on the Na+-K+-ATPase activity in the rats' brain cortex. CONCLUSION: KA systemic application induced Na+, K+- ATPase activity inhibition in the rat hippocampus and cortex and LTG pre-treatment showed a partially protective effect on the enzyme activity.


Subject(s)
Anticonvulsants/pharmacology , Brain/drug effects , Kainic Acid/pharmacology , Seizures/metabolism , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Sodium-Potassium-Exchanging ATPase/metabolism , Triazines/pharmacology , Animals , Behavior, Animal/drug effects , Brain/enzymology , Brain/metabolism , Cerebral Cortex/drug effects , Cerebral Cortex/enzymology , Cerebral Cortex/metabolism , Disease Models, Animal , Electroencephalography/statistics & numerical data , Hippocampus/drug effects , Hippocampus/enzymology , Hippocampus/metabolism , Lamotrigine , Rats , Rats, Wistar , Seizures/chemically induced , Seizures/enzymology , Sodium Channels/drug effects , Sodium Channels/metabolism , Sodium-Potassium-Exchanging ATPase/drug effects
3.
Blood Press Suppl ; 2: 33-41, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16429641

ABSTRACT

The aim of our study was to investigate blood pressure (BP) control and different factors with possible influence on BP control in Croatian hypertensive patients. In this cross-sectional investigation, a representative sample of target populations (primary care physicians and patients) from different parts of Croatia was included according to the study protocol. During December 2003 and January 2004, we included, according to correctly completed questionnaires, 141 physicians and 814 hypertensive patients. A controlled BP (BP < 140/90 mmHg) in this hypertensive population treated with antihypertensive drugs was in 23% of patients. The analysis of BP control according to risk factors showed that significantly related with higher levels of systolic or diastolic BP were the age (poorer systolic BP control in patients older than 60 years), left ventricular hypertrophy, changes of the eye retina, smoking and diabetes mellitus. Furthermore, patients from towns closer to the hospital, from urban centers, with higher education and employed had significantly lower average BP. According to our results of hypertension control in Croatia, there is a need and a possibility for the improvement of the quality of hypertension care. The relationship between demographic and cardiovascular risk factors with poor BP control should be taken into account when treating patients.


Subject(s)
Blood Pressure/physiology , Hypertension/drug therapy , Adult , Aged , Aged, 80 and over , Antihypertensive Agents/therapeutic use , Blood Pressure/drug effects , Croatia/epidemiology , Cross-Sectional Studies , Drug Utilization , Family Practice , Female , Humans , Hypertension/epidemiology , Hypertension/physiopathology , Male , Middle Aged , Patients , Physicians , Sample Size , Surveys and Questionnaires
4.
Article in English | MEDLINE | ID: mdl-15276692

ABSTRACT

The effects of hyperbaric oxygen (HBO) treatment on the Na+,K+ -ATPase and superoxide dismutase (SOD) activities were examined in the optic nerves of the rats exposed to global cerebral ischemia. Animals were exposed to global cerebral ischemia of 20-min duration and were either sacrificed or exposed to the first HBO treatment immediately, 0.5, 1, 2, 6, 24, 48, 72 or 168 h after ischemic procedure (for Na+,K+ -ATPase activities measurement) or 2, 24, 48 or 168 h after ischemia (for SOD activities measurement). HBO procedure was repeated for 7 consecutive days. It was found that global cerebral ischemia induced a statistically significant decrease in the Na+,K+ -ATPase activity of the optic nerves, starting from 0.5 to 168 h of reperfusion. Maximal enzymatic inhibition was registered 24 h after the ischemic damage. The decline in the Na+,K+ -ATPase activity was prevented in the animals exposed to HBO treatment within the first 6 h of reperfusion. The results of the presented experiments demonstrated also a statistically significant increase in the SOD activity after 24, 48 and 168 h of reperfusion in the optic nerves of non-HBO-treated ischemic animals as well as in the ischemic animals treated with HBO. Our results indicate that global cerebral ischemia induced a significant alterations in the Na+,K+ -ATPase and SOD activities in the optic nerves during different periods of reperfusion. HBO treatment, started within the first 6 h of reperfusion, prevented ischemia-induced changes in the Na+,K+ -ATPase activity, while the level of the SOD activity in the ischemic animals was not changed after HBO administration.


Subject(s)
Brain Ischemia/enzymology , Hyperbaric Oxygenation , Optic Nerve/enzymology , Sodium-Potassium-Exchanging ATPase/metabolism , Superoxide Dismutase/metabolism , Adenosine Triphosphate/biosynthesis , Animals , Optic Nerve/drug effects , Oxidants/metabolism , Rats , Rats, Wistar , Reperfusion Injury/enzymology , Superoxides/metabolism
5.
Neurochem Int ; 44(8): 585-94, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15016473

ABSTRACT

The influence of hyperbaric oxygen (HBO) treatment on the activities of superoxide dismutase (SOD) and Na(+),K(+)-ATPase was determined during different time periods of reperfusion in rats exposed to global cerebral ischemia. Ischemic animals were either sacrificed or exposed to the first HBO treatment 2, 24, 48 or 168 h after ischemic insult (for SOD activities measurement) or immediately, 0.5, 1, 2, 6, 24, 48, 72 or 168 h after ischemic procedure (for Na(+),K(+)-ATPase activities measurement). Hyperbaric oxygenation procedure was repeated for seven consecutive days. The results of presented experiments demonstrated the statistically significant increase in the hippocampal SOD activity 24 and 48 h after global cerebral ischemia followed by a decrease in the enzymatic activity 168 h after ischemic insult. In the ischemic rats treated with HBO the level of hippocampal SOD activity was significantly higher after 168 h of reperfusion in comparison to the ischemic, non HBO-treated animals. In addition, it was found that global cerebral ischemia induced a statistically significant decrease of the hippocampal Na(+),K(+)-ATPase activity starting from 1 to 168 h of reperfusion. Maximal enzymatic inhibition was obtained 24 h after the ischemic damage. Decline in Na(+),K(+)-ATPase activity was prevented in the animals exposed to HBO treatment within the first 24 h of reperfusion. Our results suggest that global cerebral ischemia induces significant alterations in the hippocampal SOD and Na(+),K(+)-ATPase activities during different periods of reperfusion. Enhanced SOD activity and preserved Na(+),K(+)-ATPase activity within particular periods of reperfusion, could be indicators of a possible beneficial role of HBO treatment in severe brain ischemia.


Subject(s)
Brain Ischemia/enzymology , Hippocampus/enzymology , Hyperbaric Oxygenation , Sodium-Potassium-Exchanging ATPase/metabolism , Superoxide Dismutase/metabolism , Adenosine Triphosphate/metabolism , Animals , Brain Ischemia/therapy , Rats , Rats, Wistar , Reperfusion Injury/enzymology , Reperfusion Injury/therapy , Xanthine/metabolism , Xanthine Oxidase/metabolism
6.
Epilepsy Res ; 52(3): 215-25, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12536054

ABSTRACT

The anticonvulsant effects of the dihydropyridine calcium channel blockers nifedipine, nicardipine and nimodipine were studied on experimental seizures induced by intra-hippocampal injection of kainic acid (KA) in chloralhydrate anesthetized Wistar rats. The rats were anesthetized and placed in a stereotaxic apparatus. After midline incision four screw electrodes were placed over the left and right frontal and parietal cortex and KA was injected into left dorsal hippocampus via 5-microliter Hamilton microsyringe. The changes in electroencephalograph (EEG) activity and EEG power spectra were recorded in basal conditions and 5, 10, 15, 30 and 60 min following KA injection. KA-induced excitatory changes in the surface EEG activity were associated with the marked increase in EEG power spectra in the frequency range from 14.5-22 Hz. Pretreatment with nifedipine, nicardipine and nimodipine revealed that they exerted certain differences in their anticonvulsant properties. Nimodipine significantly delayed the onset of seizures and prevented the KA-induced changes in EEG and in EEG power spectra in all recorded channels and in a dose dependent manner. Nifedipine exerted significant anticonvulsant effect only in channel four, while nicardipine was ineffective. Our results suggest that anticonvulsant action of some dihydropyridine calcium channel blockers, especially nimodipine may be in part independent of its antagonism on L-type voltage-gated calcium (Ca(2+)) channels.


Subject(s)
Calcium Channel Blockers/pharmacology , Excitatory Amino Acid Agonists/toxicity , Kainic Acid/toxicity , Seizures/physiopathology , Animals , Anticonvulsants/therapeutic use , Electroencephalography , Hippocampus/drug effects , Hippocampus/physiopathology , Kainic Acid/administration & dosage , Rats , Rats, Wistar , Seizures/chemically induced , Seizures/drug therapy
7.
Neurochem Int ; 42(2): 173-8, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12421597

ABSTRACT

The whole brain free fatty acid (FFA) level, as well as the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPX) were determined in the frontal cortex, cerebellum, hippocampus, and pons-medulla region of the single pentylenetetrazol (PZT)-treated and PZT-kindled Hannover-Wistar rats. PZT administration in the convulsive dose caused significant increase of the brain FFA content. Decreased SOD activity was detected in the frontal cortex of PZT-kindled rats, whereas decreased GPX activity was found in the frontal cortex and cerebellum of all treated rats, as well as in the hippocampus and pons-medulla of PZT-kindled rats. Kindling caused distinctive change of antioxidative defense in the frontal cortex, hippocampus, and pons-medulla region.


Subject(s)
Brain/enzymology , Fatty Acids, Nonesterified/metabolism , Glutathione Peroxidase/metabolism , Kindling, Neurologic/drug effects , Pentylenetetrazole , Seizures/metabolism , Superoxide Dismutase/metabolism , Animals , Brain/drug effects , Cerebellum/enzymology , Cerebellum/metabolism , Epilepsy, Tonic-Clonic/chemically induced , Epilepsy, Tonic-Clonic/enzymology , Epilepsy, Tonic-Clonic/metabolism , Female , Hippocampus/enzymology , Hippocampus/metabolism , Medulla Oblongata/enzymology , Medulla Oblongata/metabolism , Prefrontal Cortex/enzymology , Prefrontal Cortex/metabolism , Rats , Rats, Wistar , Seizures/chemically induced , Seizures/enzymology
8.
Prog Neuropsychopharmacol Biol Psychiatry ; 26(7-8): 1319-26, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12502020

ABSTRACT

The influence of 20 min global cerebral ischemia on the free arachidonic acid (FAA) level and Na+,K+-ATPase activity in the rat hippocampus at different time points after ischemia was examined. In addition, the effect of MK-801 on mentioned parameters was studied. Animals were exposed to 20 min global cerebral ischemia and were sacrificed immediately, 0.5, 1, 2, 6, 24, 48, 72, and 168 h after ischemic procedure. The level of the FAA and the Na+,K+-ATPase activity was measured during all reperfusion periods examined. Various doses of MK-801 (0.3, 1.0, 3.0, and 5.0 mg/kg) had been injected 30 min before ischemic procedure started. It was found that 20 min global cerebral ischemia induces a statistically significant increase of the FAA level immediately after ischemia and during the first 0.5 h of reperfusion. After a transient decrease, the level of FAA level increased again after 24 and 168 h of recirculation. Treatment with 3.0 mg/kg of MK-801 significantly prevented the FAA accumulation immediately and 0.5 h after ischemic insult while application of 5.0 mg/kg of MK-801 exerted a protective effect during the first 24 h. Global cerebral ischemia induces the significant decline in the Na+,K+-ATPase activity in the hippocampus starting from 1 to 168 h of reperfusion. Maximal inhibition was obtained 24 h after the ischemic damage. Application of 3.0 mg/kg of MK-801 exerted statistically significant protection during the first 24 h while the treatment with 5.0 mg/kg of MK-801 prevented fall in enzymatic activity during all reperfusion periods examined. Our results suggest that, in spite of different and complex pathophysiological mechanisms involved in the increase of FAA level and the decrease of the Na+,K+-ATPase activity, blockade of NMDA receptor subtype provides a very important strategy for the treatment of the postischemic excitotoxicity.


Subject(s)
Arachidonic Acid/analysis , Brain Ischemia/pathology , Dizocilpine Maleate/pharmacology , Hippocampus/chemistry , Neuroprotective Agents/pharmacology , Sodium-Potassium-Exchanging ATPase/analysis , Animals , Hippocampus/drug effects , Hippocampus/enzymology , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...